Hodnota podniku společnosti co.don AG

Jaká je hodnota metriky Hodnota podniku společnosti co.don AG?

Hodnota metriky Hodnota podniku společnosti co.don AG je $55.08M

Jaká je definice metriky Hodnota podniku?



Podniková hodnota (Enterprise value) je měřítkem celkové tržní hodnoty společnosti. Vypočítává se jako tržní kapitalizace s dluhem, menšinovým podílem a přednostními akciemi sníženými o celkovou hodnotu dostupných peněz a jejich ekvivalentů.

It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.

Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.

Hodnota podniku společností v sektoru Health Care sektor na XETRA ve srovnání se společností co.don AG

Čemu se věnuje společnost co.don AG?

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.

Firmy s metrikou hodnota podniku podobnou společnosti co.don AG